Company Overview
Snapshot
Founded in June 2021, Revium Rx operates with 1–10 employees. The company completed the acquisition of LipoVation Ltd. in February 2025, a strategic move to enhance its nanoparticle drug development capabilities.
Business overview
Revium Rx develops advanced delivery systems for various indications, focusing on hard-to-treat diseases by enhancing and improving encapsulated therapeutics. The company's pipeline includes antibiotics for antimicrobial-resistant bacteria, an immune checkpoint inhibitor adjuvant for solid tumors, and a novel immunization platform. Operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery, Revium Rx serves the global market with its B2B business model.
Strategic signal
Revium Rx's acquisition of LipoVation Ltd. in February 2025 signals a significant strategic expansion in its nanoparticle drug development capabilities. This move is poised to accelerate the company's efforts in tackling critical health challenges like antibiotic resistance and cancer, demonstrating a clear intent to strengthen its position in advanced drug delivery systems and broaden its therapeutic horizons.
Log in to access full profile ›Company Intelligence Q&A
- What is Revium Rx's core focus?
- Revium Rx focuses on developing advanced delivery systems for various indications, aiming to expand therapeutic horizons for hard-to-treat diseases by enhancing encapsulated therapeutics.
- What was a key strategic development for Revium Rx in early 2025?
- In February 2025, Revium Rx completed the acquisition of LipoVation Ltd., a move aimed at bolstering its nanoparticle drug development capabilities.
- What specific areas does Revium Rx's current pipeline address?
- Revium Rx's current pipeline includes antibiotics for antimicrobial-resistant bacteria, an immune checkpoint inhibitor adjuvant for solid tumors, and a novel immunization platform.
- What is the primary sector in which Revium Rx operates?
- Revium Rx operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drug Delivery.
- What is the significance of Revium Rx's nanoparticle technology?
- Revium Rx's nanoparticle technology, highlighted in March 2025, aims to tackle critical issues such as antibiotic resistance and other challenging medical conditions.